Influence of Different Light Dose on the Adverse Effect of Swallowing for Esophageal Carcinoma
NCT05174117 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57
Last updated 2021-12-30
Summary
The purpose of this experiment is to study the alleviating effects and side effects of different laser irradiation doses on esophageal stricture of esophageal cancer in order to find the appropriate dose of light.
Conditions
- Esophagus Cancer
Interventions
- COMBINATION_PRODUCT
-
single irradiation
46-48h irradiation after photosensitizer injection: power density: 200mW·cm-2, irradiation time: 900s, volume density: 180 J·cm-2
- COMBINATION_PRODUCT
-
Double irradiation
46-48h, 72h after photosensitizer injection, divided into two irradiation times: power density: 200mW·cm-2, irradiation time: 900s, volume density: 180 J·cm-2;Power density: 200mW·cm-2, irradiation time: 300s, volume density: 60 J·cm-2.
Sponsors & Collaborators
-
The First Affiliated Hospital of Henan University of Science and Technology
lead OTHER
Principal Investigators
-
Shegan Gao, MD, PhD · The First Affiliated Hospital of Clinical Medicine of Henan University of Science and Technology
-
Tanyou Shan, MD, PhD · The First Affiliated Hospital and Clinical Medicine of Henan University of Science and Technology
-
Caihong Dong, MD, PhD · The First Affiliated Hospital and Clinical Medicine of Henan University of Science and Technology
-
Wanying Li, MD · The First Affiliated Hospital and Clinical Medicine of Henan University of Science and Technology
-
Jiachun Sun, MD, PhD · The First Affiliated Hospital and Clinical Medicine of Henan University of Science and Technology
-
Mengxi Zhang, MD, PhD · The First Affiliated Hospital and Clinical Medicine of Henan University of Science and Technology
-
Xiaozhi Yuan, MD, PhD · The First Affiliated Hospital and Clinical Medicine of Henan University of Science and Technology
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-01-01
- Primary Completion
- 2022-12-31
- Completion
- 2023-06-30
Countries
- China
Study Locations
More Related Trials
-
Comparing 61.2 Gy Radiotherapy Dose Versus 50.4 Gy Radiotherapy Dose for Locally Advanced Esophageal Carcinoma
NCT03790553 ·Status: UNKNOWN ·Phase: PHASE3
-
S-1 and Radiotherapy in Elderly Patients With Esophageal Cancer
NCT01175447 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study Of Camrelizumab With Or Without Radiotherapy In The Treatment Of Esophageal Cancer
NCT04512417 ·Status: UNKNOWN ·Phase: PHASE2
-
A Comparative Study of Endoscopic Submucosal Dissection and Photodynamic Therapy for Early Esophageal Cancer
NCT05208775 ·Status: UNKNOWN ·Phase: NA
-
Improve the Treatment of Thoracic Esophageal Cancer
NCT01137123 ·Status: COMPLETED ·Phase: PHASE3
-
Irinotecan Plus S1 Versus S1 in Patients With Previously Treated Advanced Esophageal Cancer: ESWN 01 Trial
NCT02319187 ·Status: UNKNOWN ·Phase: PHASE3
-
S-1 and Radiotherapy for Elderly Esophageal Cancer Patients
NCT02716688 ·Status: WITHDRAWN ·Phase: PHASE2
-
Neoadjuvant Immunotherapy (PD-1 / PD-L1) Combined With Chemotherapy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: a Single Center, Prospective, Open, One Arm Exploratory Clinical Study
NCT05028231 ·Status: UNKNOWN
-
Low-Dose Radiotherapy in Patients With Advanced Esophageal Squamous Cell Carcinoma Resistant to First-Line Chemotherapy Combined With Immunotherapy
NCT07164690 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
PET/CT-directed Hyperfractionated Radiation Dose Escalation in Esophageal Cancer
NCT03113214 ·Status: COMPLETED ·Phase: NA
-
Effect of Concurrent Chemoradiation Therapy on Respiratory Muscle Performance, Lung Function and Functional Capacity in Patients With Local Esophagus Cancer
NCT03120572 ·Status: COMPLETED
-
Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer
NCT04046575 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy Concurrent With Chemotherapy for Esophageal Squamous Cell Carcinoma
NCT02916511 ·Status: COMPLETED ·Phase: PHASE2
-
IMRT/Pemetrexed/Cisplatin in Esophageal Cancer
NCT01630174 ·Status: UNKNOWN
-
High Dose PET/CT-guided Intensity Modulated Radiotherapy and Concurrent Chemotherapy in Esophageal Cancer
NCT03936179 ·Status: UNKNOWN ·Phase: NA
-
Simultaneous Modulated Accelerated Boost Versus Standard Dose Radiotherapy in Esophageal Cancer
NCT02556762 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Postoperative Chemoradiation in Patients With Node-positive Esophageal Squamous Cell Carcinoma
NCT02446574 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Definitive (Chemo)Radiotherapy for Patients With Esophageal Cancer - 3JECROG R-01
NCT03298204 ·Status: COMPLETED
-
Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal Carcinoma
NCT05937438 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Palliative Radiotherapy and Brachytherapy for Oesophageal Cancer Dysphagia
NCT00665197 ·Status: COMPLETED ·Phase: PHASE3
-
Concurrent Chemoradiotherapy After Endoscopic Resection for Stage I Esophageal Carcinoma
NCT04275986 ·Status: UNKNOWN ·Phase: PHASE2
-
Quality of Life Assessment of Patients Receiving Treatment for Esophageal Cancer [Companion to CALGB-9781]
NCT00003381 ·Status: TERMINATED
-
Endoscopic Surgery or Radiation Therapy in Treating Patients With Stage 0, Stage I, or Stage II Laryngeal Cancer of the Glottis
NCT00334997 ·Status: COMPLETED ·Phase: PHASE2
-
Concurrent Chemoradiotherapy for Stage IVB Esophageal Squamous Cell Carcinoma(EC-CRT-003)
NCT05512520 ·Status: RECRUITING ·Phase: PHASE2
-
High-dose Intensity Modulated Radiotherapy and Concurrent Chemotherapy in Esophageal Cancer
NCT03535207 ·Status: UNKNOWN ·Phase: NA